Zhu H, Wei L, Liu X, Liu S, Chen H, Chen P
Viruses. 2023; 15(11).
PMID: 38005924
PMC: 10674415.
DOI: 10.3390/v15112247.
Lubisi B, Mutowembwa P, Ndouvhada P, Odendaal L, Bastos A, Penrith M
Viruses. 2023; 15(2).
PMID: 36851759
PMC: 9964260.
DOI: 10.3390/v15020545.
Barrera-Zarate J, Detmer S, Pasternak J, Hamonic G, MacPhee D, Harding J
Vet Pathol. 2022; 59(6):940-949.
PMID: 35723036
PMC: 9530517.
DOI: 10.1177/03009858221105053.
Jeong C, Nazki S, Kim S, Khatun A, Noh Y, Lee D
Arch Virol. 2022; 167(2):425-439.
PMID: 35079900
DOI: 10.1007/s00705-021-05303-8.
Malgarin C, Moser F, Pasternak J, Hamonic G, Detmer S, MacPhee D
BMC Vet Res. 2021; 17(1):182.
PMID: 33933084
PMC: 8088663.
DOI: 10.1186/s12917-021-02883-0.
Commercial PRRS Modified-Live Virus Vaccines.
Chae C
Vaccines (Basel). 2021; 9(2).
PMID: 33671826
PMC: 7926738.
DOI: 10.3390/vaccines9020185.
Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection.
Van Goor A, Pasternak A, Walker K, Hong L, Malgarin C, MacPhee D
BMC Genomics. 2020; 21(1):763.
PMID: 33148169
PMC: 7640517.
DOI: 10.1186/s12864-020-07154-0.
Assessment of the Impact of the Recombinant Porcine Reproductive and Respiratory Syndrome Virus Horsens Strain on the Reproductive Performance in Pregnant Sows.
Genis S, Kvisgaard L, Larsen L, Taylor L, Calvert J, Balasch M
Pathogens. 2020; 9(9).
PMID: 32967283
PMC: 7559163.
DOI: 10.3390/pathogens9090772.
A modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine protects late-term pregnancy gilts against a heterologous PRRSV-2 challenge.
Yang S, Kang I, Cho H, Oh T, Park K, Min K
Can J Vet Res. 2020; 84(3):172-180.
PMID: 32801451
PMC: 7301676.
Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related to the probability of transmission of Porcine Reproductive and Respiratory Syndrome virus (PRRSv) to naive pigs via fresh meat.
EFSA J. 2020; 3(8):239.
PMID: 32313575
PMC: 7163481.
DOI: 10.2903/j.efsa.2005.239.
Potential of small-molecule fungal metabolites in antiviral chemotherapy.
Roy B
Antivir Chem Chemother. 2017; 25(2):20-52.
PMID: 28737040
PMC: 5890529.
DOI: 10.1177/2040206617705500.
Emergence of a virulent porcine reproductive and respiratory syndrome virus (PRRSV) 1 strain in Lower Austria.
Sinn L, Klingler E, Lamp B, Brunthaler R, Weissenbock H, Rumenapf T
Porcine Health Manag. 2017; 2:28.
PMID: 28405454
PMC: 5382404.
DOI: 10.1186/s40813-016-0044-z.
Genome-wide analysis of the transcriptional response to porcine reproductive and respiratory syndrome virus infection at the maternal/fetal interface and in the fetus.
Wilkinson J, Bao H, Ladinig A, Hong L, Stothard P, Lunney J
BMC Genomics. 2016; 17:383.
PMID: 27207143
PMC: 4875603.
DOI: 10.1186/s12864-016-2720-4.
The Attenuation Phenotype of a Ribavirin-Resistant Porcine Reproductive and Respiratory Syndrome Virus Is Maintained during Sequential Passages in Pigs.
Khatun A, Shabir N, Seo B, Kim B, Yoon K, Kim W
J Virol. 2016; 90(9):4454-4468.
PMID: 26889041
PMC: 4836337.
DOI: 10.1128/JVI.02836-15.
Maternal and fetal predictors of fetal viral load and death in third trimester, type 2 porcine reproductive and respiratory syndrome virus infected pregnant gilts.
Ladinig A, Ashley C, Detmer S, Wilkinson J, Lunney J, Plastow G
Vet Res. 2015; 46:107.
PMID: 26407558
PMC: 4582889.
DOI: 10.1186/s13567-015-0251-7.
Different clinical, virological, serological and tissue tropism outcomes of two new and one old Belgian type 1 subtype 1 porcine reproductive and respiratory virus (PRRSV) isolates.
Frydas I, Trus I, Kvisgaard L, Bonckaert C, Reddy V, Li Y
Vet Res. 2015; 46:37.
PMID: 25885416
PMC: 4367851.
DOI: 10.1186/s13567-015-0166-3.
Variation in fetal outcome, viral load and ORF5 sequence mutations in a large scale study of phenotypic responses to late gestation exposure to type 2 porcine reproductive and respiratory syndrome virus.
Ladinig A, Wilkinson J, Ashley C, Detmer S, Lunney J, Plastow G
PLoS One. 2014; 9(4):e96104.
PMID: 24756023
PMC: 3996001.
DOI: 10.1371/journal.pone.0096104.
Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus (MLV) vaccine strains in a young pig infection model.
Martinez-Lobo F, de Lome L, Diez-Fuertes F, Segales J, Garcia-Artiga C, Simarro I
Vet Res. 2013; 44:115.
PMID: 24308693
PMC: 4028782.
DOI: 10.1186/1297-9716-44-115.
Pathogenesis and prevention of placental and transplacental porcine reproductive and respiratory syndrome virus infection.
Karniychuk U, Nauwynck H
Vet Res. 2013; 44:95.
PMID: 24099529
PMC: 4021427.
DOI: 10.1186/1297-9716-44-95.
Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
Geldhof M, Vanhee M, Van Breedam W, Van Doorsselaere J, Karniychuk U, Nauwynck H
BMC Vet Res. 2012; 8:182.
PMID: 23031319
PMC: 3514241.
DOI: 10.1186/1746-6148-8-182.